The U.S. Preclinical Imaging Market was valued at USD 1.12 Billion in 2025 and is projected to reach USD 1.85 Billion by 2035, while Europe is expected to grow from USD 1.28 Billion to USD 1.95 Billion, driven by expanding pharmaceutical research, imaging biomarker adoption, and advanced preclinical research infrastructure.
The U.S. Preclinical Imaging Market was valued at USD 1.12 Billion in 2025 and is projected to reach USD 1.85 Billion by 2035, while Europe is expected to grow from USD 1.28 Billion to USD 1.95 Billion, driven by expanding pharmaceutical research, imaging biomarker adoption, and advanced preclinical research infrastructure.